Stance Capital LLC Abb Vie Inc. Transaction History
Stance Capital LLC
- $161 Billion
- Q4 2024
A detailed history of Stance Capital LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Stance Capital LLC holds 9,652 shares of ABBV stock, worth $1.87 Million. This represents 1.06% of its overall portfolio holdings.
Number of Shares
9,652Holding current value
$1.87 Million% of portfolio
1.06%Shares
1 transactions
Others Institutions Holding ABBV
# of Institutions
4,169Shares Held
1.29BCall Options Held
17MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA173MShares$33.5 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$26.4 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$15.4 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$10 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$7.68 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $342B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...